These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 9533519

  • 1. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
    Lee DH, Yang SC, Hong SJ, Chung BH, Kim IY.
    Clin Cancer Res; 1998 Mar; 4(3):535-8. PubMed ID: 9533519
    [Abstract] [Full Text] [Related]

  • 2. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L, Bialkowska-Hobrzanska H, Bukala B, Nott L, Razvi H.
    Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
    Dalbagni G, Han W, Zhang ZF, Cordon-Cardo C, Saigo P, Fair WR, Herr H, Kim N, Moore MA.
    Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
    [Abstract] [Full Text] [Related]

  • 4. Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes.
    Yang SC, Lee DH, Hong SJ, Chung BH, Kim IY.
    Yonsei Med J; 1997 Jun; 38(3):155-9. PubMed ID: 9259615
    [Abstract] [Full Text] [Related]

  • 5. Telomerase activity in patients with transitional cell carcinoma: a preliminary study.
    Rahat MA, Lahat N, Gazawi H, Resnick MB, Sova Y, Ben-Ari G, Cohen M, Stein A.
    Cancer; 1999 Feb 15; 85(4):919-24. PubMed ID: 10091771
    [Abstract] [Full Text] [Related]

  • 6. Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy.
    Leach FS, Hsieh JT, Molberg K, Saboorian MH, McConnell JD, Sagalowsky AI.
    Cancer; 2000 May 15; 88(10):2333-41. PubMed ID: 10820356
    [Abstract] [Full Text] [Related]

  • 7. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
    Bian W, Xu Z.
    Int J Urol; 2007 Feb 15; 14(2):108-11. PubMed ID: 17302565
    [Abstract] [Full Text] [Related]

  • 8. Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine.
    Heine B, Hummel M, Müller M, Heicappell R, Miller K, Stein H.
    J Pathol; 1998 Jan 15; 184(1):71-6. PubMed ID: 9582530
    [Abstract] [Full Text] [Related]

  • 9. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
    May M, Hakenberg OW, Gunia S, Pohling P, Helke C, Lübbe L, Nowack R, Siegsmund M, Hoschke B.
    Urology; 2007 Sep 15; 70(3):449-53. PubMed ID: 17688921
    [Abstract] [Full Text] [Related]

  • 10. Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise.
    Cassel A, Rahat MA, Lahat N, Lindenfeld N, Mecz Y, Stein A.
    J Urol; 2001 Sep 15; 166(3):841-4. PubMed ID: 11490230
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of cytology, nuclear matrix protein 22 (NMP22) test, and urinary bladder cancer II (UBC II) test in early recurrent transitional cell carcinoma of the bladder.
    Kibar Y, Goktas S, Kilic S, Yaman H, Onguru O, Peker AF.
    Ann Clin Lab Sci; 2006 Sep 15; 36(1):31-8. PubMed ID: 16501234
    [Abstract] [Full Text] [Related]

  • 12. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R, Dal Canto M, Cai T, Piazzini M, Travaglini F, Gavazzi A, Rizzo M.
    Oncol Rep; 2005 Mar 15; 13(3):531-7. PubMed ID: 15706429
    [Abstract] [Full Text] [Related]

  • 13. [Telomerase activity as marker of superficial tumor of the bladder].
    Arias Fúnez F, Fernández Fernández E, Escudero Barrilero A, Moyano Jato A, Caso Peláez E.
    Arch Esp Urol; 2000 Apr 15; 53(3):231-6. PubMed ID: 10851728
    [Abstract] [Full Text] [Related]

  • 14. Telomerase activity in human bladder cancer.
    Lin Y, Miyamoto H, Fujinami K, Uemura H, Hosaka M, Iwasaki Y, Kubota Y.
    Clin Cancer Res; 1996 Jun 15; 2(6):929-32. PubMed ID: 9816252
    [Abstract] [Full Text] [Related]

  • 15. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M, Drullinsky P, Guillem J, Moore MA.
    Clin Cancer Res; 1997 Nov 15; 3(11):1931-41. PubMed ID: 9815582
    [Abstract] [Full Text] [Related]

  • 16. Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay.
    Gelmini S, Crisci A, Salvadori B, Pazzagli M, Selli C, Orlando C.
    Clin Cancer Res; 2000 Jul 15; 6(7):2771-6. PubMed ID: 10914723
    [Abstract] [Full Text] [Related]

  • 17. Telomerase activity is correlated with lower grade and lower stage bladder carcinomas.
    Okumura A, Mizuno I, Nagakawa O, Fuse H.
    Int J Urol; 2004 Dec 15; 11(12):1082-6. PubMed ID: 15663679
    [Abstract] [Full Text] [Related]

  • 18. Comparison of screening methods in the detection of bladder cancer.
    Ramakumar S, Bhuiyan J, Besse JA, Roberts SG, Wollan PC, Blute ML, O'Kane DJ.
    J Urol; 1999 Feb 15; 161(2):388-94. PubMed ID: 9915409
    [Abstract] [Full Text] [Related]

  • 19. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A, Kumar R, Gupta NP.
    Jpn J Clin Oncol; 2006 Mar 15; 36(3):172-5. PubMed ID: 16520358
    [Abstract] [Full Text] [Related]

  • 20. Telomerase activity in urine sediments as a tool for noninvasive detection of bladder cancer.
    Dettlaff-Pokora A, Matuszewski M, Schlichtholz B.
    Cancer Lett; 2005 May 10; 222(1):83-8. PubMed ID: 15837544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.